nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Capecitabine—kidney cancer	0.0168	0.458	CbGbCtD
Treprostinil—CYP2C9—Paclitaxel—kidney cancer	0.0105	0.287	CbGbCtD
Treprostinil—CYP2C9—Sorafenib—kidney cancer	0.00933	0.255	CbGbCtD
Treprostinil—Pruritus—Erlotinib—kidney cancer	0.000592	0.000903	CcSEcCtD
Treprostinil—Fatigue—Dactinomycin—kidney cancer	0.000591	0.000902	CcSEcCtD
Treprostinil—Epistaxis—Capecitabine—kidney cancer	0.000591	0.000901	CcSEcCtD
Treprostinil—Pain—Dactinomycin—kidney cancer	0.000587	0.000895	CcSEcCtD
Treprostinil—Tension—Paclitaxel—kidney cancer	0.000585	0.000893	CcSEcCtD
Treprostinil—Anorexia—Vincristine—kidney cancer	0.000584	0.000891	CcSEcCtD
Treprostinil—Oedema—Gemcitabine—kidney cancer	0.000581	0.000887	CcSEcCtD
Treprostinil—Nervousness—Paclitaxel—kidney cancer	0.000579	0.000883	CcSEcCtD
Treprostinil—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000578	0.000881	CcSEcCtD
Treprostinil—Infection—Gemcitabine—kidney cancer	0.000578	0.000881	CcSEcCtD
Treprostinil—Back pain—Paclitaxel—kidney cancer	0.000577	0.00088	CcSEcCtD
Treprostinil—Dizziness—Vinblastine—kidney cancer	0.000576	0.000878	CcSEcCtD
Treprostinil—Dizziness—Everolimus—kidney cancer	0.000574	0.000875	CcSEcCtD
Treprostinil—Muscle spasms—Paclitaxel—kidney cancer	0.000574	0.000875	CcSEcCtD
Treprostinil—Abdominal pain—Sunitinib—kidney cancer	0.000573	0.000874	CcSEcCtD
Treprostinil—Body temperature increased—Sunitinib—kidney cancer	0.000573	0.000874	CcSEcCtD
Treprostinil—Diarrhoea—Erlotinib—kidney cancer	0.000573	0.000873	CcSEcCtD
Treprostinil—Hypotension—Vincristine—kidney cancer	0.000573	0.000873	CcSEcCtD
Treprostinil—Bradycardia—Capecitabine—kidney cancer	0.000572	0.000873	CcSEcCtD
Treprostinil—Thrombocytopenia—Gemcitabine—kidney cancer	0.000569	0.000868	CcSEcCtD
Treprostinil—Feeling abnormal—Dactinomycin—kidney cancer	0.000565	0.000862	CcSEcCtD
Treprostinil—Haemoglobin—Capecitabine—kidney cancer	0.000565	0.000862	CcSEcCtD
Treprostinil—Rhinitis—Capecitabine—kidney cancer	0.000564	0.00086	CcSEcCtD
Treprostinil—Haemorrhage—Capecitabine—kidney cancer	0.000562	0.000858	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000561	0.000855	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000558	0.000852	CcSEcCtD
Treprostinil—Pharyngitis—Capecitabine—kidney cancer	0.000558	0.000851	CcSEcCtD
Treprostinil—Insomnia—Vincristine—kidney cancer	0.000554	0.000845	CcSEcCtD
Treprostinil—Anorexia—Gemcitabine—kidney cancer	0.000554	0.000845	CcSEcCtD
Treprostinil—Oedema peripheral—Capecitabine—kidney cancer	0.000554	0.000845	CcSEcCtD
Treprostinil—Vomiting—Vinblastine—kidney cancer	0.000554	0.000844	CcSEcCtD
Treprostinil—Dizziness—Erlotinib—kidney cancer	0.000554	0.000844	CcSEcCtD
Treprostinil—Ill-defined disorder—Paclitaxel—kidney cancer	0.000553	0.000844	CcSEcCtD
Treprostinil—Vomiting—Everolimus—kidney cancer	0.000552	0.000841	CcSEcCtD
Treprostinil—Anaemia—Paclitaxel—kidney cancer	0.000551	0.000841	CcSEcCtD
Treprostinil—Paraesthesia—Vincristine—kidney cancer	0.00055	0.000839	CcSEcCtD
Treprostinil—Rash—Everolimus—kidney cancer	0.000547	0.000834	CcSEcCtD
Treprostinil—Dermatitis—Everolimus—kidney cancer	0.000547	0.000833	CcSEcCtD
Treprostinil—Headache—Vinblastine—kidney cancer	0.000546	0.000832	CcSEcCtD
Treprostinil—Angioedema—Paclitaxel—kidney cancer	0.000545	0.000831	CcSEcCtD
Treprostinil—Headache—Everolimus—kidney cancer	0.000544	0.000829	CcSEcCtD
Treprostinil—Hypotension—Gemcitabine—kidney cancer	0.000543	0.000829	CcSEcCtD
Treprostinil—Abdominal pain—Dactinomycin—kidney cancer	0.000542	0.000827	CcSEcCtD
Treprostinil—Body temperature increased—Dactinomycin—kidney cancer	0.000542	0.000827	CcSEcCtD
Treprostinil—Asthenia—Sorafenib—kidney cancer	0.00054	0.000824	CcSEcCtD
Treprostinil—Malaise—Paclitaxel—kidney cancer	0.000538	0.00082	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—kidney cancer	0.000537	0.000819	CcSEcCtD
Treprostinil—Syncope—Paclitaxel—kidney cancer	0.000535	0.000816	CcSEcCtD
Treprostinil—Decreased appetite—Vincristine—kidney cancer	0.000533	0.000813	CcSEcCtD
Treprostinil—Pruritus—Sorafenib—kidney cancer	0.000533	0.000813	CcSEcCtD
Treprostinil—Vomiting—Erlotinib—kidney cancer	0.000532	0.000812	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00053	0.000808	CcSEcCtD
Treprostinil—Fatigue—Vincristine—kidney cancer	0.000528	0.000806	CcSEcCtD
Treprostinil—Rash—Erlotinib—kidney cancer	0.000528	0.000805	CcSEcCtD
Treprostinil—Dermatitis—Erlotinib—kidney cancer	0.000527	0.000804	CcSEcCtD
Treprostinil—Palpitations—Paclitaxel—kidney cancer	0.000527	0.000804	CcSEcCtD
Treprostinil—Insomnia—Gemcitabine—kidney cancer	0.000526	0.000802	CcSEcCtD
Treprostinil—Headache—Erlotinib—kidney cancer	0.000524	0.0008	CcSEcCtD
Treprostinil—Loss of consciousness—Paclitaxel—kidney cancer	0.000524	0.000799	CcSEcCtD
Treprostinil—Pain—Vincristine—kidney cancer	0.000524	0.000799	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—kidney cancer	0.000524	0.000799	CcSEcCtD
Treprostinil—Paraesthesia—Gemcitabine—kidney cancer	0.000522	0.000796	CcSEcCtD
Treprostinil—Flushing—Capecitabine—kidney cancer	0.000522	0.000796	CcSEcCtD
Treprostinil—Cough—Paclitaxel—kidney cancer	0.000521	0.000794	CcSEcCtD
Treprostinil—Asthenia—Sunitinib—kidney cancer	0.00052	0.000793	CcSEcCtD
Treprostinil—Dyspnoea—Gemcitabine—kidney cancer	0.000518	0.000791	CcSEcCtD
Treprostinil—Nausea—Vinblastine—kidney cancer	0.000517	0.000789	CcSEcCtD
Treprostinil—Nausea—Everolimus—kidney cancer	0.000515	0.000786	CcSEcCtD
Treprostinil—Diarrhoea—Sorafenib—kidney cancer	0.000515	0.000786	CcSEcCtD
Treprostinil—Pruritus—Sunitinib—kidney cancer	0.000513	0.000782	CcSEcCtD
Treprostinil—Arthralgia—Paclitaxel—kidney cancer	0.000508	0.000774	CcSEcCtD
Treprostinil—Chest pain—Paclitaxel—kidney cancer	0.000508	0.000774	CcSEcCtD
Treprostinil—Myalgia—Paclitaxel—kidney cancer	0.000508	0.000774	CcSEcCtD
Treprostinil—Anxiety—Paclitaxel—kidney cancer	0.000506	0.000772	CcSEcCtD
Treprostinil—Decreased appetite—Gemcitabine—kidney cancer	0.000505	0.000771	CcSEcCtD
Treprostinil—Discomfort—Paclitaxel—kidney cancer	0.000502	0.000765	CcSEcCtD
Treprostinil—Fatigue—Gemcitabine—kidney cancer	0.000501	0.000764	CcSEcCtD
Treprostinil—Gastrointestinal pain—Vincristine—kidney cancer	0.000501	0.000764	CcSEcCtD
Treprostinil—Dizziness—Sorafenib—kidney cancer	0.000498	0.000759	CcSEcCtD
Treprostinil—Pain—Gemcitabine—kidney cancer	0.000497	0.000758	CcSEcCtD
Treprostinil—Nausea—Erlotinib—kidney cancer	0.000497	0.000758	CcSEcCtD
Treprostinil—Diarrhoea—Sunitinib—kidney cancer	0.000496	0.000756	CcSEcCtD
Treprostinil—Asthenia—Dactinomycin—kidney cancer	0.000492	0.000751	CcSEcCtD
Treprostinil—Erythema—Capecitabine—kidney cancer	0.00049	0.000746	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—kidney cancer	0.000487	0.000743	CcSEcCtD
Treprostinil—Oedema—Paclitaxel—kidney cancer	0.000487	0.000742	CcSEcCtD
Treprostinil—Body temperature increased—Vincristine—kidney cancer	0.000485	0.000739	CcSEcCtD
Treprostinil—Abdominal pain—Vincristine—kidney cancer	0.000485	0.000739	CcSEcCtD
Treprostinil—Infection—Paclitaxel—kidney cancer	0.000484	0.000738	CcSEcCtD
Treprostinil—Dizziness—Sunitinib—kidney cancer	0.000479	0.000731	CcSEcCtD
Treprostinil—Feeling abnormal—Gemcitabine—kidney cancer	0.000479	0.000731	CcSEcCtD
Treprostinil—Shock—Paclitaxel—kidney cancer	0.000479	0.00073	CcSEcCtD
Treprostinil—Vomiting—Sorafenib—kidney cancer	0.000479	0.00073	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—kidney cancer	0.000477	0.000727	CcSEcCtD
Treprostinil—Thrombocytopenia—Paclitaxel—kidney cancer	0.000477	0.000727	CcSEcCtD
Treprostinil—Tachycardia—Paclitaxel—kidney cancer	0.000475	0.000725	CcSEcCtD
Treprostinil—Rash—Sorafenib—kidney cancer	0.000475	0.000724	CcSEcCtD
Treprostinil—Dermatitis—Sorafenib—kidney cancer	0.000474	0.000723	CcSEcCtD
Treprostinil—Back pain—Capecitabine—kidney cancer	0.000474	0.000722	CcSEcCtD
Treprostinil—Headache—Sorafenib—kidney cancer	0.000472	0.000719	CcSEcCtD
Treprostinil—Muscle spasms—Capecitabine—kidney cancer	0.000471	0.000718	CcSEcCtD
Treprostinil—Diarrhoea—Dactinomycin—kidney cancer	0.000469	0.000716	CcSEcCtD
Treprostinil—Anorexia—Paclitaxel—kidney cancer	0.000464	0.000708	CcSEcCtD
Treprostinil—Vomiting—Sunitinib—kidney cancer	0.000461	0.000703	CcSEcCtD
Treprostinil—Body temperature increased—Gemcitabine—kidney cancer	0.00046	0.000701	CcSEcCtD
Treprostinil—Rash—Sunitinib—kidney cancer	0.000457	0.000697	CcSEcCtD
Treprostinil—Dermatitis—Sunitinib—kidney cancer	0.000457	0.000696	CcSEcCtD
Treprostinil—Hypotension—Paclitaxel—kidney cancer	0.000455	0.000694	CcSEcCtD
Treprostinil—Ill-defined disorder—Capecitabine—kidney cancer	0.000454	0.000693	CcSEcCtD
Treprostinil—Headache—Sunitinib—kidney cancer	0.000454	0.000692	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—kidney cancer	0.000453	0.000691	CcSEcCtD
Treprostinil—Anaemia—Capecitabine—kidney cancer	0.000452	0.00069	CcSEcCtD
Treprostinil—Nausea—Sorafenib—kidney cancer	0.000447	0.000682	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000444	0.000676	CcSEcCtD
Treprostinil—Malaise—Capecitabine—kidney cancer	0.000441	0.000673	CcSEcCtD
Treprostinil—Insomnia—Paclitaxel—kidney cancer	0.00044	0.000671	CcSEcCtD
Treprostinil—Asthenia—Vincristine—kidney cancer	0.00044	0.000671	CcSEcCtD
Treprostinil—Syncope—Capecitabine—kidney cancer	0.000439	0.000669	CcSEcCtD
Treprostinil—Paraesthesia—Paclitaxel—kidney cancer	0.000437	0.000667	CcSEcCtD
Treprostinil—Vomiting—Dactinomycin—kidney cancer	0.000436	0.000665	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—kidney cancer	0.000436	0.000664	CcSEcCtD
Treprostinil—Dyspnoea—Paclitaxel—kidney cancer	0.000434	0.000662	CcSEcCtD
Treprostinil—Palpitations—Capecitabine—kidney cancer	0.000433	0.00066	CcSEcCtD
Treprostinil—Rash—Dactinomycin—kidney cancer	0.000433	0.00066	CcSEcCtD
Treprostinil—Nausea—Sunitinib—kidney cancer	0.00043	0.000656	CcSEcCtD
Treprostinil—Loss of consciousness—Capecitabine—kidney cancer	0.00043	0.000656	CcSEcCtD
Treprostinil—Dyspepsia—Paclitaxel—kidney cancer	0.000429	0.000653	CcSEcCtD
Treprostinil—Cough—Capecitabine—kidney cancer	0.000427	0.000651	CcSEcCtD
Treprostinil—Decreased appetite—Paclitaxel—kidney cancer	0.000423	0.000645	CcSEcCtD
Treprostinil—Fatigue—Paclitaxel—kidney cancer	0.00042	0.00064	CcSEcCtD
Treprostinil—Diarrhoea—Vincristine—kidney cancer	0.000419	0.00064	CcSEcCtD
Treprostinil—Asthenia—Gemcitabine—kidney cancer	0.000417	0.000636	CcSEcCtD
Treprostinil—Myalgia—Capecitabine—kidney cancer	0.000417	0.000636	CcSEcCtD
Treprostinil—Chest pain—Capecitabine—kidney cancer	0.000417	0.000636	CcSEcCtD
Treprostinil—Arthralgia—Capecitabine—kidney cancer	0.000417	0.000636	CcSEcCtD
Treprostinil—Pain—Paclitaxel—kidney cancer	0.000416	0.000635	CcSEcCtD
Treprostinil—Anxiety—Capecitabine—kidney cancer	0.000415	0.000633	CcSEcCtD
Treprostinil—Discomfort—Capecitabine—kidney cancer	0.000412	0.000628	CcSEcCtD
Treprostinil—Pruritus—Gemcitabine—kidney cancer	0.000411	0.000627	CcSEcCtD
Treprostinil—Nausea—Dactinomycin—kidney cancer	0.000408	0.000621	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—kidney cancer	0.000406	0.000619	CcSEcCtD
Treprostinil—Dizziness—Vincristine—kidney cancer	0.000405	0.000618	CcSEcCtD
Treprostinil—PPARD—Metabolism—CA2—kidney cancer	0.000405	0.00132	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IFNA2—kidney cancer	0.000405	0.00132	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—MYC—kidney cancer	0.000402	0.00131	CbGpPWpGaD
Treprostinil—Feeling abnormal—Paclitaxel—kidney cancer	0.000401	0.000612	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IFNA1—kidney cancer	0.0004	0.0013	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKAP13—kidney cancer	0.0004	0.0013	CbGpPWpGaD
Treprostinil—Oedema—Capecitabine—kidney cancer	0.0004	0.000609	CcSEcCtD
Treprostinil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000398	0.000607	CcSEcCtD
Treprostinil—Diarrhoea—Gemcitabine—kidney cancer	0.000398	0.000607	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000397	0.00129	CbGpPWpGaD
Treprostinil—Infection—Capecitabine—kidney cancer	0.000397	0.000605	CcSEcCtD
Treprostinil—PPARD—Metabolism—ALAD—kidney cancer	0.000395	0.00128	CbGpPWpGaD
Treprostinil—Shock—Capecitabine—kidney cancer	0.000393	0.000599	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—kidney cancer	0.000393	0.000599	CcSEcCtD
Treprostinil—Thrombocytopenia—Capecitabine—kidney cancer	0.000391	0.000596	CcSEcCtD
Treprostinil—Tachycardia—Capecitabine—kidney cancer	0.00039	0.000595	CcSEcCtD
Treprostinil—Vomiting—Vincristine—kidney cancer	0.00039	0.000594	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.000389	0.00126	CbGpPWpGaD
Treprostinil—Rash—Vincristine—kidney cancer	0.000386	0.000589	CcSEcCtD
Treprostinil—Dermatitis—Vincristine—kidney cancer	0.000386	0.000589	CcSEcCtD
Treprostinil—PPARD—Metabolism—ST3GAL2—kidney cancer	0.000385	0.00125	CbGpPWpGaD
Treprostinil—Haematuria—Doxorubicin—kidney cancer	0.000385	0.000587	CcSEcCtD
Treprostinil—Body temperature increased—Paclitaxel—kidney cancer	0.000385	0.000587	CcSEcCtD
Treprostinil—Abdominal pain—Paclitaxel—kidney cancer	0.000385	0.000587	CcSEcCtD
Treprostinil—Headache—Vincristine—kidney cancer	0.000384	0.000586	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—kidney cancer	0.000381	0.000581	CcSEcCtD
Treprostinil—Anorexia—Capecitabine—kidney cancer	0.000381	0.000581	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—kidney cancer	0.000379	0.000578	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—AMER1—kidney cancer	0.000378	0.00123	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALDH1A1—kidney cancer	0.000377	0.00122	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ITPR2—kidney cancer	0.000374	0.00122	CbGpPWpGaD
Treprostinil—Hypotension—Capecitabine—kidney cancer	0.000373	0.000569	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IFNA2—kidney cancer	0.000372	0.00121	CbGpPWpGaD
Treprostinil—Vomiting—Gemcitabine—kidney cancer	0.00037	0.000564	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—kidney cancer	0.000369	0.000563	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—AKAP13—kidney cancer	0.000368	0.0012	CbGpPWpGaD
Treprostinil—Rash—Gemcitabine—kidney cancer	0.000367	0.000559	CcSEcCtD
Treprostinil—Dermatitis—Gemcitabine—kidney cancer	0.000366	0.000559	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000365	0.00119	CbGpPWpGaD
Treprostinil—Haemoglobin—Doxorubicin—kidney cancer	0.000364	0.000556	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IGF2—kidney cancer	0.000364	0.00118	CbGpPWpGaD
Treprostinil—Headache—Gemcitabine—kidney cancer	0.000364	0.000555	CcSEcCtD
Treprostinil—Nausea—Vincristine—kidney cancer	0.000364	0.000555	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000364	0.000555	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—kidney cancer	0.000363	0.000554	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—kidney cancer	0.000362	0.000553	CcSEcCtD
Treprostinil—Insomnia—Capecitabine—kidney cancer	0.000361	0.000551	CcSEcCtD
Treprostinil—PPARD—Metabolism—SLC5A3—kidney cancer	0.000361	0.00117	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PGK1—kidney cancer	0.000361	0.00117	CbGpPWpGaD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00036	0.00117	CbGpPWpGaD
Treprostinil—Pharyngitis—Doxorubicin—kidney cancer	0.00036	0.000549	CcSEcCtD
Treprostinil—Paraesthesia—Capecitabine—kidney cancer	0.000359	0.000547	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000357	0.00116	CbGpPWpGaD
Treprostinil—Oedema peripheral—Doxorubicin—kidney cancer	0.000357	0.000545	CcSEcCtD
Treprostinil—Dyspnoea—Capecitabine—kidney cancer	0.000356	0.000543	CcSEcCtD
Treprostinil—PPARD—Metabolism—LDHB—kidney cancer	0.000354	0.00115	CbGpPWpGaD
Treprostinil—Dyspepsia—Capecitabine—kidney cancer	0.000352	0.000536	CcSEcCtD
Treprostinil—Asthenia—Paclitaxel—kidney cancer	0.000349	0.000533	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000349	0.00113	CbGpPWpGaD
Treprostinil—Decreased appetite—Capecitabine—kidney cancer	0.000347	0.00053	CcSEcCtD
Treprostinil—Nausea—Gemcitabine—kidney cancer	0.000345	0.000527	CcSEcCtD
Treprostinil—PPARD—Gene Expression—RPL14—kidney cancer	0.000345	0.00112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CER1—kidney cancer	0.000345	0.00112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GPC3—kidney cancer	0.000345	0.00112	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ITPR2—kidney cancer	0.000344	0.00112	CbGpPWpGaD
Treprostinil—Fatigue—Capecitabine—kidney cancer	0.000344	0.000525	CcSEcCtD
Treprostinil—Pruritus—Paclitaxel—kidney cancer	0.000344	0.000525	CcSEcCtD
Treprostinil—Pain—Capecitabine—kidney cancer	0.000342	0.000521	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—ITPR2—kidney cancer	0.00034	0.00111	CbGpPWpGaD
Treprostinil—Flushing—Doxorubicin—kidney cancer	0.000336	0.000513	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IGF2—kidney cancer	0.000335	0.00109	CbGpPWpGaD
Treprostinil—Diarrhoea—Paclitaxel—kidney cancer	0.000333	0.000508	CcSEcCtD
Treprostinil—Feeling abnormal—Capecitabine—kidney cancer	0.000329	0.000502	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000329	0.00107	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Capecitabine—kidney cancer	0.000327	0.000498	CcSEcCtD
Treprostinil—Dizziness—Paclitaxel—kidney cancer	0.000322	0.000491	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—GPC3—kidney cancer	0.000317	0.00103	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CER1—kidney cancer	0.000317	0.00103	CbGpPWpGaD
Treprostinil—Body temperature increased—Capecitabine—kidney cancer	0.000316	0.000482	CcSEcCtD
Treprostinil—Abdominal pain—Capecitabine—kidney cancer	0.000316	0.000482	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—kidney cancer	0.000316	0.000481	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—ANXA1—kidney cancer	0.000314	0.00102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ITPR2—kidney cancer	0.000313	0.00102	CbGpPWpGaD
Treprostinil—Tension—Doxorubicin—kidney cancer	0.00031	0.000472	CcSEcCtD
Treprostinil—Vomiting—Paclitaxel—kidney cancer	0.00031	0.000472	CcSEcCtD
Treprostinil—PPARD—Metabolism—CA9—kidney cancer	0.000307	0.000998	CbGpPWpGaD
Treprostinil—Rash—Paclitaxel—kidney cancer	0.000307	0.000468	CcSEcCtD
Treprostinil—Dermatitis—Paclitaxel—kidney cancer	0.000307	0.000468	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—kidney cancer	0.000306	0.000467	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—kidney cancer	0.000305	0.000465	CcSEcCtD
Treprostinil—Headache—Paclitaxel—kidney cancer	0.000305	0.000465	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—kidney cancer	0.000303	0.000463	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.0003	0.000976	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000296	0.000964	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000296	0.000962	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SFRP2—kidney cancer	0.000293	0.000953	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Doxorubicin—kidney cancer	0.000293	0.000446	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—kidney cancer	0.000292	0.000445	CcSEcCtD
Treprostinil—Nausea—Paclitaxel—kidney cancer	0.000289	0.000441	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—ANXA1—kidney cancer	0.000289	0.000939	CbGpPWpGaD
Treprostinil—Asthenia—Capecitabine—kidney cancer	0.000287	0.000437	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—ANXA1—kidney cancer	0.000285	0.000926	CbGpPWpGaD
Treprostinil—Malaise—Doxorubicin—kidney cancer	0.000285	0.000434	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—kidney cancer	0.000283	0.000432	CcSEcCtD
Treprostinil—Pruritus—Capecitabine—kidney cancer	0.000283	0.000431	CcSEcCtD
Treprostinil—PPARD—Gene Expression—HSPB1—kidney cancer	0.000281	0.000915	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—EIF4EBP1—kidney cancer	0.000281	0.000915	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.00028	0.000912	CbGpPWpGaD
Treprostinil—Palpitations—Doxorubicin—kidney cancer	0.000279	0.000425	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—kidney cancer	0.000277	0.000423	CcSEcCtD
Treprostinil—Cough—Doxorubicin—kidney cancer	0.000275	0.00042	CcSEcCtD
Treprostinil—Diarrhoea—Capecitabine—kidney cancer	0.000273	0.000417	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000272	0.000884	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—POMC—kidney cancer	0.000272	0.000884	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SFRP2—kidney cancer	0.00027	0.000877	CbGpPWpGaD
Treprostinil—Arthralgia—Doxorubicin—kidney cancer	0.000269	0.00041	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—kidney cancer	0.000269	0.00041	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—kidney cancer	0.000269	0.00041	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—kidney cancer	0.000268	0.000408	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.000267	0.000867	CbGpPWpGaD
Treprostinil—Discomfort—Doxorubicin—kidney cancer	0.000265	0.000405	CcSEcCtD
Treprostinil—Dizziness—Capecitabine—kidney cancer	0.000264	0.000403	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—ANXA1—kidney cancer	0.000262	0.000852	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PSMD7—kidney cancer	0.000262	0.00085	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CRABP1—kidney cancer	0.000261	0.000849	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTT1—kidney cancer	0.00026	0.000846	CbGpPWpGaD
Treprostinil—Oedema—Doxorubicin—kidney cancer	0.000258	0.000393	CcSEcCtD
Treprostinil—Infection—Doxorubicin—kidney cancer	0.000256	0.00039	CcSEcCtD
Treprostinil—Vomiting—Capecitabine—kidney cancer	0.000254	0.000387	CcSEcCtD
Treprostinil—Shock—Doxorubicin—kidney cancer	0.000253	0.000386	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—kidney cancer	0.000252	0.000384	CcSEcCtD
Treprostinil—Rash—Capecitabine—kidney cancer	0.000252	0.000384	CcSEcCtD
Treprostinil—Dermatitis—Capecitabine—kidney cancer	0.000252	0.000384	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—kidney cancer	0.000251	0.000383	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000251	0.000816	CbGpPWpGaD
Treprostinil—Headache—Capecitabine—kidney cancer	0.00025	0.000382	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—POMC—kidney cancer	0.00025	0.000814	CbGpPWpGaD
Treprostinil—Anorexia—Doxorubicin—kidney cancer	0.000245	0.000374	CcSEcCtD
Treprostinil—CYP2C9—Biological oxidations—PTGS1—kidney cancer	0.000244	0.000793	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ITPR2—kidney cancer	0.000243	0.000789	CbGpPWpGaD
Treprostinil—Hypotension—Doxorubicin—kidney cancer	0.000241	0.000367	CcSEcCtD
Treprostinil—Nausea—Capecitabine—kidney cancer	0.000237	0.000362	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—AKAP13—kidney cancer	0.000236	0.000768	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP2—kidney cancer	0.000236	0.000768	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—JUNB—kidney cancer	0.000235	0.000763	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000235	0.000358	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—kidney cancer	0.000233	0.000355	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.000232	0.000753	CbGpPWpGaD
Treprostinil—Paraesthesia—Doxorubicin—kidney cancer	0.000231	0.000353	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—kidney cancer	0.00023	0.00035	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—kidney cancer	0.000227	0.000346	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—kidney cancer	0.000224	0.000341	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000224	0.000727	CbGpPWpGaD
Treprostinil—Fatigue—Doxorubicin—kidney cancer	0.000222	0.000339	CcSEcCtD
Treprostinil—PPARD—Metabolism—ACHE—kidney cancer	0.000221	0.000719	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTT1—kidney cancer	0.000221	0.000719	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000221	0.000717	CbGpPWpGaD
Treprostinil—Pain—Doxorubicin—kidney cancer	0.00022	0.000336	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CASP2—kidney cancer	0.000217	0.000707	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKAP13—kidney cancer	0.000217	0.000707	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GRB7—kidney cancer	0.000216	0.000702	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000215	0.000699	CbGpPWpGaD
Treprostinil—Feeling abnormal—Doxorubicin—kidney cancer	0.000212	0.000324	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000211	0.000321	CcSEcCtD
Treprostinil—PPARD—Metabolism—SCARB1—kidney cancer	0.000209	0.000681	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS1—kidney cancer	0.000207	0.000674	CbGpPWpGaD
Treprostinil—Body temperature increased—Doxorubicin—kidney cancer	0.000204	0.00031	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—kidney cancer	0.000204	0.00031	CcSEcCtD
Treprostinil—PPARD—Metabolism—PSMD7—kidney cancer	0.000203	0.000661	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ITPR2—kidney cancer	0.000201	0.000653	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—RAF1—kidney cancer	0.0002	0.000652	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GRB7—kidney cancer	0.000199	0.000646	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—BCHE—kidney cancer	0.000193	0.000627	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CDKN2B—kidney cancer	0.000191	0.000621	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC5A5—kidney cancer	0.00019	0.000619	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ITPR2—kidney cancer	0.000185	0.000601	CbGpPWpGaD
Treprostinil—Asthenia—Doxorubicin—kidney cancer	0.000185	0.000282	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—RAF1—kidney cancer	0.000185	0.0006	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC2A1—kidney cancer	0.000184	0.000598	CbGpPWpGaD
Treprostinil—Pruritus—Doxorubicin—kidney cancer	0.000182	0.000278	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CTNNA1—kidney cancer	0.000182	0.000592	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HSPB1—kidney cancer	0.000181	0.000589	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EIF4EBP1—kidney cancer	0.000181	0.000589	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTP1—kidney cancer	0.00018	0.000586	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—kidney cancer	0.00018	0.000585	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000178	0.00058	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	0.000178	0.000578	CbGpPWpGaD
Treprostinil—Diarrhoea—Doxorubicin—kidney cancer	0.000176	0.000269	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—kidney cancer	0.00017	0.00026	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—TSC1—kidney cancer	0.000168	0.000547	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ANXA1—kidney cancer	0.000168	0.000547	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSMD7—kidney cancer	0.000168	0.000547	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNA1—kidney cancer	0.000168	0.000545	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HSPB1—kidney cancer	0.000167	0.000542	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000167	0.000542	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTM1—kidney cancer	0.000166	0.000539	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—kidney cancer	0.000165	0.000538	CbGpPWpGaD
Treprostinil—Vomiting—Doxorubicin—kidney cancer	0.000164	0.00025	CcSEcCtD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	0.000163	0.000531	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FLT1—kidney cancer	0.000163	0.00053	CbGpPWpGaD
Treprostinil—Rash—Doxorubicin—kidney cancer	0.000162	0.000248	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—kidney cancer	0.000162	0.000247	CcSEcCtD
Treprostinil—Headache—Doxorubicin—kidney cancer	0.000161	0.000246	CcSEcCtD
Treprostinil—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	0.000157	0.000511	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000156	0.000506	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	0.000155	0.000504	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSMD7—kidney cancer	0.000155	0.000504	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ANXA1—kidney cancer	0.000155	0.000504	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSC1—kidney cancer	0.000155	0.000504	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—kidney cancer	0.000154	0.0005	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—POMC—kidney cancer	0.000154	0.0005	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTP1—kidney cancer	0.000153	0.000499	CbGpPWpGaD
Treprostinil—Nausea—Doxorubicin—kidney cancer	0.000153	0.000233	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—VEGFA—kidney cancer	0.000153	0.000497	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUNB—kidney cancer	0.000151	0.000491	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PAK1—kidney cancer	0.000151	0.000491	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FLT1—kidney cancer	0.00015	0.000488	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCB1—kidney cancer	0.000145	0.000472	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK3—kidney cancer	0.000145	0.00047	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—kidney cancer	0.000141	0.00046	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—kidney cancer	0.000141	0.000458	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—kidney cancer	0.000141	0.000457	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—kidney cancer	0.00014	0.000454	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUNB—kidney cancer	0.000139	0.000452	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PAK1—kidney cancer	0.000139	0.000452	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACY1—kidney cancer	0.000138	0.000449	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK1—kidney cancer	0.000138	0.000447	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1A1—kidney cancer	0.000134	0.000434	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK3—kidney cancer	0.000133	0.000432	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—kidney cancer	0.00013	0.000422	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—kidney cancer	0.000128	0.000418	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK1—kidney cancer	0.000127	0.000412	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—kidney cancer	0.000124	0.000402	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN2B—kidney cancer	0.000123	0.0004	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—kidney cancer	0.00012	0.000389	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1R—kidney cancer	0.000119	0.000388	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—kidney cancer	0.000119	0.000388	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000118	0.000383	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PDHB—kidney cancer	0.000118	0.000382	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—kidney cancer	0.000117	0.000381	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—kidney cancer	0.000115	0.000375	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RAF1—kidney cancer	0.000115	0.000374	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—kidney cancer	0.000114	0.00037	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—kidney cancer	0.000114	0.000369	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN2B—kidney cancer	0.000113	0.000368	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CCBL1—kidney cancer	0.00011	0.000359	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1R—kidney cancer	0.00011	0.000357	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—kidney cancer	0.00011	0.000357	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.00011	0.000357	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—kidney cancer	0.000106	0.000345	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RAF1—kidney cancer	0.000106	0.000344	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—kidney cancer	0.000105	0.00034	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—kidney cancer	0.000103	0.000335	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	9.99e-05	0.000325	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—kidney cancer	9.96e-05	0.000324	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HIF1A—kidney cancer	9.83e-05	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TSC2—kidney cancer	9.81e-05	0.000319	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPAT—kidney cancer	9.58e-05	0.000311	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLIPR1—kidney cancer	9.58e-05	0.000311	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—kidney cancer	9.49e-05	0.000309	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	9.46e-05	0.000308	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—kidney cancer	9.4e-05	0.000306	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	9.36e-05	0.000304	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HIF1A—kidney cancer	9.05e-05	0.000294	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSC2—kidney cancer	9.02e-05	0.000293	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APRT—kidney cancer	8.91e-05	0.00029	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FH—kidney cancer	8.91e-05	0.00029	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.7e-05	0.000283	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APC—kidney cancer	8.66e-05	0.000282	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—kidney cancer	8.66e-05	0.000282	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—kidney cancer	8.65e-05	0.000281	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPC3—kidney cancer	8.37e-05	0.000272	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—kidney cancer	8.29e-05	0.00027	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—kidney cancer	8.24e-05	0.000268	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA2—kidney cancer	8.14e-05	0.000265	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BRAF—kidney cancer	8.14e-05	0.000265	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APC—kidney cancer	7.97e-05	0.000259	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—kidney cancer	7.97e-05	0.000259	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—kidney cancer	7.95e-05	0.000258	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALAD—kidney cancer	7.94e-05	0.000258	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK1—kidney cancer	7.89e-05	0.000257	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	7.75e-05	0.000252	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—kidney cancer	7.63e-05	0.000248	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—kidney cancer	7.61e-05	0.000248	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—kidney cancer	7.59e-05	0.000247	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	7.57e-05	0.000246	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—kidney cancer	7.54e-05	0.000245	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BRAF—kidney cancer	7.49e-05	0.000244	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—kidney cancer	7.45e-05	0.000242	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—kidney cancer	7.41e-05	0.000241	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK1—kidney cancer	7.26e-05	0.000236	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PGK1—kidney cancer	7.26e-05	0.000236	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC5A3—kidney cancer	7.26e-05	0.000236	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LDHB—kidney cancer	7.12e-05	0.000231	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—kidney cancer	6.94e-05	0.000226	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTEN—kidney cancer	6.93e-05	0.000225	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—kidney cancer	6.86e-05	0.000223	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—kidney cancer	6.85e-05	0.000223	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAF1—kidney cancer	6.8e-05	0.000221	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RELA—kidney cancer	6.77e-05	0.00022	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB2—kidney cancer	6.72e-05	0.000219	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—kidney cancer	6.64e-05	0.000216	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—kidney cancer	6.3e-05	0.000205	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAF1—kidney cancer	6.26e-05	0.000203	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RELA—kidney cancer	6.23e-05	0.000202	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—kidney cancer	6.23e-05	0.000202	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB2—kidney cancer	6.19e-05	0.000201	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA9—kidney cancer	6.17e-05	0.000201	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—kidney cancer	6.11e-05	0.000199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—kidney cancer	6.09e-05	0.000198	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.03e-05	0.000196	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—kidney cancer	5.94e-05	0.000193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—kidney cancer	5.93e-05	0.000193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—kidney cancer	5.88e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTEN—kidney cancer	5.73e-05	0.000186	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—kidney cancer	5.73e-05	0.000186	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—kidney cancer	5.61e-05	0.000182	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—kidney cancer	5.47e-05	0.000178	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—kidney cancer	5.46e-05	0.000177	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—kidney cancer	5.41e-05	0.000176	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTEN—kidney cancer	5.28e-05	0.000172	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CRABP1—kidney cancer	5.25e-05	0.000171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—kidney cancer	5.18e-05	0.000168	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—kidney cancer	4.9e-05	0.000159	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—kidney cancer	4.89e-05	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ITPR2—kidney cancer	4.88e-05	0.000159	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—kidney cancer	4.77e-05	0.000155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—kidney cancer	4.77e-05	0.000155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK1—kidney cancer	4.66e-05	0.000152	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—kidney cancer	4.51e-05	0.000147	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.5e-05	0.000146	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACHE—kidney cancer	4.45e-05	0.000145	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—kidney cancer	4.45e-05	0.000145	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—kidney cancer	4.4e-05	0.000143	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—kidney cancer	4.39e-05	0.000143	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK1—kidney cancer	4.29e-05	0.00014	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SCARB1—kidney cancer	4.21e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS1—kidney cancer	4.17e-05	0.000136	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMD7—kidney cancer	4.09e-05	0.000133	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—kidney cancer	4.05e-05	0.000132	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—kidney cancer	4.05e-05	0.000132	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—kidney cancer	3.91e-05	0.000127	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BCHE—kidney cancer	3.88e-05	0.000126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.83e-05	0.000124	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—kidney cancer	3.72e-05	0.000121	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.7e-05	0.00012	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—kidney cancer	3.6e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.59e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.13e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—kidney cancer	3.08e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—kidney cancer	2.92e-05	9.49e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—kidney cancer	2.83e-05	9.22e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.69e-05	8.74e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.21e-05	7.18e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—kidney cancer	2e-05	6.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—kidney cancer	1.6e-05	5.2e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTEN—kidney cancer	1.39e-05	4.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—kidney cancer	9.83e-06	3.2e-05	CbGpPWpGaD
